Skip to main menu Skip to main content Skip to footer

University Retina and Macular Associates

University Retina is a full-service practice that specializes in helping patients heal eyesight-robbing diseases of the retina, vitreous, and macula. Led by a team of board-certified ophthalmologists and retina specialists, the practice has locations in Oak Forest, Bedford Park, Lemont, and Downers Grove, Illinois.

With a dedication to education, technology, charity, and compassionate care, the University Retina team strives to provide patients with the highest level of retinal care in the world. The physicians diagnose and treat retinal-related conditions, including macular degeneration, diabetic retinopathy, retinal detachment repair, and other disorders of the retina, vitreous, and macula.

All University Retina offices are equipped with state-of-the-art technology, and each patient’s treatment plan includes the most current and effective therapies or services available.

The team at University Retina looks forward to helping you resolve your symptoms, regain your eye health, and live the healthiest life possible.

Investigator

Veeral S. Sheth

Veeral S. Sheth
MD, MBA, FASRS, FACS

Locations

Bedford Park

7456 South State Road, Suite 103
Bedford Park, IL 60638

Downers Grove

1 East 22nd Street Suite 100
Lombard, IL 60148

Lemont

15947 West 127th Street, Suite E
Lemont, IL 60439

Oak Forest

6320 W 159th Street
Oak Forest, IL 60452

Awards and Publications

Publications
Chapters
Presentations
Other

Publications

Veeral S. Sheth, MD, MBA, FASRS, FACS

  • Khanani AM, Aziz AA, Khan H, Gupta A, Mojumder O, Saulebayeva A, Abbey AM, Almedia DRP, Avery RL, Banda HK, Barakat MR, Bhandari R, Chang EY, Haug SJ, London NJS, Mein L, Sheth VS, Wolfe JD, Singer MA, Danzig CJ. The real-world efficacy and safety of faricimab in neovascular age-relatd macular degeneration: the TRUCKEE study- 6 month results. Eye 2023.
  • Patel PN, Patel PA, Land MR, Bakerkhatib-Taha I, Ahmed H, Sheth V. Targeting the complement cascade for treatment of dry age-related macular degeneration. Biomedicines 2022,10,1884.
  • Sheth V, D’Rozario M, Gune S, Blotner S. Fluctuations in central foveal thickness and association with vision outcomes with anti-VEGF therapy for nAMD: HARBOR post hoc analysis. BMJ Open Ophth 2022;7e000957.
  • Poor SH, Weissgerber G, Adams CM, Bhatt H, Browning DJ, Chastain J, Ciulla TA, Ferriere M, Gedif K, Glazer LC, Joondeph BC, Normand G, Sheth V, Watters C, Grosskreutz CL. A randomized, double-masked, multicenter trial of topical acrizanib (LHA510), a tyrosine kinase VEGF-receptor inhibitor, in treatment-experienced subjects with neovascular age-related macular degeneration. AJO 2022, in press.
  • Singer M, Sheth V, Mansour SE, Coughlin B, Gonzalez VH. Three-year safety and efficacy of the 0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: the PALADIN study. Ophthalmology, 2022 in press.
  • Graff J, Sheth V, Chang RT, Menezes A, Barteselli G, Malhotra V. Conjunctiva and Tenon’s capsule handling in the Port Delivery System with ranibizumab implant insertion procedure: surgical pearls. Ophthalmic Surg Lasers Imaging Retina, 2022 53(5):266-273.
  • Patel P, Sheth V. New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD). J. Clin. Med. 2021, 10(11): 2436.
  • Sokol JT, Schechet SA, Komati R, Eliott D, Vavvas DG, Kaplan RI, Ittiara ST, Farooq AV, Sheth VS, MacCumber MW, Ke R, Gentile RC, Skondra D. Macular hole closure with medical treatment. Ophthalmology Retina. 2021 Apr;5(4):348-356.
  • Tsipursky M, Byun M, Jager R, Sheth V. Anatomical and functional outcomes of relaxing parafoveal nasal retinotomy for refractory macular hole repair. Journal of Vitreoretinal Diseases. 2021 accepted.
  • Yu HJ, Kiernan DF, Eichenbaum D, Sheth V, Wykoff C. Home monitoring of age-related macular degeneration: utility of the ForeseeHome device for detection of neovascularization. Ophthalmology Retina. 2021 Apr;5(4)348-356.
  • Bhagat D, Kirby B, Bhatt H, Jager R, George M, Sheth V. Patient preferences associated with anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration and diabetic macular edema. Clinical Ophthalmology. 2020 Oct: 14: 2975-2982.
  • Sheth V, Hariprasad SM, Dhoot D. Private equity’s game plan and why it should matter to us. Ophthalmic Surg Lasers Imaging Retina. 2020 Aug;51(8):424-427.
  • Oh DJ, Sheth V, Fishman GA, Grassi MA. Simplex crumbs homologue 1 maculopathy masquerading as juvenile X-linked retinoschisis in male patients. J Vitreoretin Dis. 2020 Oct;4(5):437-440.
  • Horton MB, Brady CJ, Cavallerano J, Abramoff M, Barker G, Chiang MF, Crockett CH, Garg S, Karth P, Liu Y, Newman CD, Rathi S, Sheth V, Silva P, Stebbins K, Zimmer-Galler I. Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition. Telemedicine and e-Health, 2020 Apr; 26(4):1-50.
  • Eichenbaum DA, Buznego C, Weng CY, Dhoot DS, Wykoff CC, Sheth VS. When and how to incorporate steroids for persistent macular edema: A discussion of real-world treatment optimization strategies. Ophthalmic Surg Lasers Imaging Retina. 2018 Jul 1;49(7):S5-S15.
  • Dunn EN, Hariprasad SM, Sheth VS. An overview of the Fovista and rinucumab trials and the fate of anti-PDGF medications. Ophthalmic Surg Lasers Imaging Retina. 2017 Feb 1;48(2):100-104.
  • Sahni S, Watson RM, Sheth VS. Actinomyces neuii endophthalmitis after intravitreal anti-VEGF injection. Retina Cases and Brief Reports. 2017 Summer;11(3):281-282.
  • Metelitsina TI, Sheth VS, Patel SB, Grassi MA. Peripheral retinopathy associated with aplastic anemia. Retina Cases and Brief Reports. 2017 Spring;11(2):108-110.
  • Afshar AR, Fernandes JK, Patel RD, Ksiazek SM, Sheth VS, Reder AT, Hariprasad SM. Cystoid macular edema assoiciated with fingolimod use for multiple sclerosis. Arch Ophthalmol. 2013 Jan; 131(1):103-7.
  • Afshar AR, Hariprasad SM, Jampol LM, Sheth VS. Use of intravitreous bevacizumab to treat macular edema in west nile virus chroioretinitis. Arch Ophthalmol. 2012 Mar; 130(3):396-8.
  • Kiernan DF, Lin TK, Sheth V, Jager RD. Pharmacotherapy of retinal diseases with ranibizumab. Clinical Medicine: Therapeutics. 2009 Apr:175-182.
  • Sheth V, Shapiro M. Detection of facial hypotonia and diagnosis of FSHD. Arch Ophthalmol. 2008 May; 126:745-6.
  • Shukla D, Scanlan P, Tiwari V, Sheth V, Clement C, Guzman-Hartman G, Dermody TS, Valyi-Nagy T. Expression of nectin-1 in the normal and HSV-1-infected murine brain. Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):341-7.
  • Valyi-Nagy T, Sheth V, Clement C, Tiwari V, Scanlan P, Kavouras JH, Guzman-Hartman G, Dermody TS, Shukla D. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Current Eye Research. 2004 Oct-Nov;29(4-5):303-309.

Chapters

Veeral S. Sheth, MD, MBA, FASRS, FACS

  • Sheth V, Zaslau S, Casanova R, eds. Lippincott Q&A Medicine: Review for Clinical Rotations and Exams. Baltimore: Lippincott, Williams & Wilkins, 2015.
  • Sheth V, Zaslau S, Casanova R, eds. Shelf-Life Surgery. Baltimore: Lippincott, Williams & Wilkins, 2014.
  • Sheth V, Zaslau S, Casanova R, eds. Shelf-Life Obstetrics and Gynecology. Baltimore: Lippincott, Williams & Wilkins, 2014.
  • Sheth V, Zaslau S, Casanova R, eds. Shelf-Life Pediatrics. Baltimore: Lippincott, Williams & Wilkins, 2014.
  • Sheth V, Marcet M, Chiranand P, Bhatt HK, Lamkin JC, Jager RD. The Massachusetts Eye and Ear Infirmary Review Manual for Ophthalmology, Fourth Edition. Baltimore: Lippincott, Williams & Wilkins, 2011.

Presentations

Veeral S. Sheth, MD, MBA, FASRS, FACS

  • Barakat MR, Aziz A, Khan H, Lauer E, Mohan N, Viruni N, Mishra K, Nielsen JS, Abbey AM, Almeida D, Corradetti G, Haug SJ, Sheth VS, Sadda SR, Khanani AM. Retinal fluid quantification using a novel AI-based algorithm in patients treated with faricimab in the TRUCKEE study: First time results. ASRS presentation, 2023.
  • Eichenbaum DA, Holekamp NM, Khanani AM, Pieramici DJ, Hershberger VS, Sheth VS, Ma L, Brunstein F, Indjeian V, Hsu J, Dere R, Maia M, Gao S, Willis J, Wiley H, Chen H. Efficacy and safety of anti-high temperature requirement A1 (aHtrA1) Fab in geographic atrophy (GA) secondary to AMD: Gallego phase 2 randomized trial. ASRS presentation, 2023.
  • Nezgoda J, Aziz A, Khan H, Khan Hu, Abbey AM, Almeida D, Avery RL, Banda H, Barakat MR, Bhandari R, Chang EY, Corradetti G, Danzig CJ, Graff JM, Haug SJ, Javaheri M, Liu EM, London NJ, Nielson J, Sadda SR, Sheth VS, Singer MA, Wolfe JD, Wong RW, Khanani AM. Real world efficacy, durability, and safety of faricimab in diabetic macular edema: the TAHOE study. ASRS presentation, 2023.
  • Sheth V. Three-year outcomes from the PALADIN phase IV study: a comparison of anatomical metrics pre- and post-0.19mg fluocinolone acetonide treatment and their relationship to efficacy and treatment burden outcomes. Retina Society presentation, 2022.
  • Sheth V, Khan H, Aziz AA, Abbey AM, Almedia DRP, Avery RL, Banda HK, Barakat MR, Bhandari R, Chang EY, Danzig CJ, Haug SJ, London NJS, Singer MA, Wolfe JD, Khanani AM. Real world efficacy, durability, and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study. Euretina paper presentation, 2022.
  • Sheth V. Three year outcomes from the PALADIN phase IV study: a comparison of anatomical metrics pre- and post-0.19mg fluocinolone acetonide treatment and their relationship to efficacy and treatment burden outcomes. Euretina paper presentation, 2022.
  • Barakat M, Singh RP, Ip M, Higgins PM, Sheth V, Eichenbaum D, Wykoff C, Kim YS, He F, Cho G, Wang Y, Emanuelli A. Brolucizumab for the treatment of diabetic macular edema: 52-week results from the KINGFISHER study. Euretina paper presentation, 2022.
  • Sheth V, Blotner S, Heinrich D, Gune S, Chakravarthy U. Central subfield thickness fluctuations and their impact on vision outcomes over 96 weeks in the Archway trial of the PDS. ASRS paper presentation, 2022.
  • Bhagat D, Bhatt H, Chittaluru N, George M, Jager R, Patel P, Sheth V. Evaluating patient perspective regarding telehealth for retinal disease during the COVID-19 pandemic. ASRS poster presentation, 2022.
  • Holekamp N, Adam MK, Chi G, Garmo V, Gentile B, Lambert J, Lewis H, Mirt M, Pahwa A, Sheth V. Patient and caregiver experience with anti-VEGF intravitreal injections to treat neovascular age-related macular degeneration and diabetic macular edema in the US. ASRS poster presentation, 2022.
  • Khan H, Eichenbaum D, Ewing T, Graff T, Khan M, Khanani A, Masud M, Sheth V, Sulahria H. Real world efficacy and safety of the ranibizumab port-delivery system in neovascular AMD: the SUMMIT study. ASRS poster presentation, 2022.
  • Sheth V, Peto T, Lambert J, Lewis H, Barbier V, Gentile B, Mirt M, Chi G. Patient experience with anti-VEGF intravitreal injections in neovascular age-related macular degeneration and diabetic macular edema: a multinational observational study. ARVO poster presentation, 2022.
  • Modi Y, Csaky K, Sheth V, Willis J, Haskova Z, Westenskow P. Angiopoietin-2 (Ang-2) signaling and vascular stability with faricimab in diabetic macular edema (DME). ARVO poster presentation, 2022.
  • Chittaluru N, Bhagat D, Patel P, Sheth V. Patient perspective of telehealth for retinal disease during the COVID-19 pandemic. ARVO poster presentation, 2022.
  • Sheth V, Khanani A, Chuidian M, Dinh P, Zamiri P. Intravitreal sunitinib malate depot (GB-102): durability and safety in wet age-related macular degeneration (ALTISSIMO, phase 2B). AAO late-breaker presentation, 2021.
  • Danzig C, Khanani AM, Eichenbaum D, Wykoff CC, Hsu J, Lally DR, Sheth V, Heier JS, Patel SS, Nielsen J. Avacincaptad pegol demonstrates continued reduction in GA growth: GATHER1 18-month results. AAO poster, 2021.
  • Baumal C, Loewenstein A, Sheth VS, Csaky K, Edmonds R, Chang M, Willis JR, Haskova Z, Westenskow PD. Exploring Ang-2 signaling in vascular stability in patients with DME receiving faricimab in phase 2 and phase 3 trials. Retina Society paper presentation, 2021.
  • Loewenstein A, Sheth VS, Csaky K, Edmonds R, Chang M, Willis JR, Haskova Z, Westenskow PD. Exploring Ang-2 signaling in vascular stability in patients with DME receiving faricimab in phase 2 and phase 3 trials. Euretina Prize Paper Presentation, 2021.
  • Sheth VS, Loewenstein A, Csaky K, Edmonds R, Chang M, Willis JR, Haskova Z, Westenskow PD. Exploring Ang-2 signaling in vascular stability in patients with DME receiving faricimab in phase 2 and phase 3 trials. AAO poster, 2021. Awarded 2021 Best Poster Award.
  • Sheth VS, Menezes A, Malhotra V. Key pearls of conjunctival and Tenon’s capsule handling during the implant insertion procedure for the port delivery system with ranimizumab (PDS). ASRS paper presentation, 2021.
  • Sheth VS. Avacincaptad pegol, a novel C5 inhibitor, demonstrates a continued reduction in the mean rate of geographic atrophy growth: 18-month results from the GATHER1 clinical trial. ARVO paper presentation, 2021.
  • Sheth VS, Blotner S, Malhotra M, D’Rozario MR, Gune S. Fluctuations in central foveal thickness and vision outcomes with anti-VEGF therapy for neovascular age-related macular degeneration. ASRS paper presentation, 2020.
  • Bhagat D, Kirby B, Bhatt HK, Jager RD, Sheth VS. Evaluating patient preferences when receiving intravitreal injections for retinal disease: A conjoint analysis. ASRS poster presentation, 2019.
  • Sheth V. Subthrehold micropulse laser for chronic central serous chorioretinopathy. 19th Annual Club Vit Meeting. Miami, USA. July 2, 2016.
  • Miller RC, Yashraj C, Jager R, Bhatt H, Sheth V. Visual and anatomic outcomes of combined focal navigated laser photocoagulation and intravitreal anti-vascular endothelial growth factor for diabetic macular edema. ARVO poster presentation, 2015.
  • Feinstein E, Miller RC, Yashraj C, Jager R, Bhatt H, Sheth V. Visual and anatomic outcomes of focal navigated laser photocoagulation for diabetic macular edema at 12 months. ARVO poster presentation, 2015.
  • Sheth V. Subthreshold 577nm micropulse laser for diabetic macular edema. 23rd Annual Conference of the Vitreo Retinal Society of India. Agra, India. December 6, 2014.
  • Sheth V. Symptomatic vitreomacular adhesion: current options. 23rd Annual Conference of the Vitreo Retinal Society of India. Agra, India. December 5, 2014.
  • Sheth V. The perceptions of policy: the ACA and its impact on clinical practices. AMSA Training Ground Conference. Chicago, USA. November 22, 2014.
  • Sheth V. Advancements in retinal diagnostics and therapeutics. Joliet Optometric Society. Lemont, USA. January 26, 2014.
  • Sheth V. New treatments and innovations in diabetic and age-related retinal diseases. Adventist Bolingbrook Hospital Grand Rounds. Bolingbrook, IL. October 1, 2013.
  • Sheth V. Retina review. Cook County Ophthalmology Comprehensive Overview. Chicago, USA. March 3, 2013.
  • Sheth V. Advancements in retinal diagnostics and therapeutics. Joliet Optometric Society. Lemont, USA. January 27, 2013.
  • Agrawal KK, Jager RD, Bhatt HK, Sheth VS. Combination therapy of intravitreal bevacizumab and focal NAVILAS laser in the treatment of macular edema due to branch retinal vein occlusion. American Society of Retinal Specialist poster presentation, 2012.
  • Sheth V. DRCR.net treatment of DME with triamcinolone vs ranibizumab vs laser and future trials. 6th Asia-Pacific Vitreo Retina Society Congress held in conjunction with the 20th Annual Conference of the Vitreo Retinal Society of India. Hyderabad, India. December 1, 2011.
  • Sheth V. Inflammatory retinal edema. 6th Asia-Pacific Vitreo Retina Society Congress held in conjunction with the 20th Annual Conference of the Vitreo Retinal Society of India. Hyderabad, India. December 2, 2011.
  • Sheth V. Retina review. Cook County Ophthalmology Comprehensive Overview. Chicago, USA. March 20, 2010.
  • Colina-Luquez J, Mojica G, Sheth V, Hariprasad SM. Incidence of endogenous fungal endophthalmitis in patients with positive blood cultures for systemic fungemia. ARVO poster presentation, 2010.
  • Chen JJ, Eulo V, Huang Y, Rehman J, Hariprasad SM, Jager RD, Sheth V, Chiranand P, Mojica G, Nicolae DL, Lussier YA, Grassi MA. Study of genetic expression in diabetic retinopathy reveals unique molecular fingerprint. ARVO poster presentation, 2010.
  • Gabrielian A, Sheth V, Hariprasad SM. Surgical outcomes of epiretinal membrane removal with and without internal limiting membrane peel in patients with tractional retinal detachment. ARVO poster presentation, 2009.
  • Sheth V, Blair M, De la Cruz J. Macular optical coherence tomography findings in Boston type 1 keratoprosthesis patients at the Illinois Eye and Ear Infirmary. ARVO poster presentation, 2008.
  • Slover C, Sheth V, Danziger L, Tu E, Fiscella R. Evaluation of topical linezolid, daptomycin, and tigecycline compared to vancomycin in a rabbit model of Streptococcus pneumoniae corneal ulceration. ARVO poster presentation, 2007.
  • Sheth V, Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Shukla D. Herpes simplex virus receptor Nectin-1 expression in the murine eye. ARVO poster presentation, 2004.

Other

Veeral S. Sheth, MD, MBA, FASRS, FACS

  • Radcliffe N, Sheth VS. IOP changes in patients with uveitis. Retinal Physician. 2021 Sep: 28-30.
  • Sheth VS. Intraocular long-term anti-inflammatory treatment for noninfectious uveitis. Retinal Physician. 2020 Sep: 44-46.
  • Sheth, VS. Vision, drugs, and money. Ophthalmology Management. 2017 Aug:18-21.
  • Hariprasad SM, Boyer DS, Fine HF, Khurana RN, Ober MD, Sheth VS, Singer MA. Evolving strategies in the use of corticosteroids for the treatment of DME. Retinal Physician. 2015 Apr: 6-19.
  • Farooq AV, Miller RC, Sheth VS. Case of the month. The New Physician. 2015 Jan-Feb: 34-35.
  • Miller RC, Sheth VS. Removal of intraocular foreign body: new technique. ASRS.org. 2014 Dec.
  • Sheth VS, Hariprasad SM. DME drugs multiply. Ophthalmology Management. 2014 Nov; 18:16-18.
  • Collins ME, Sheth V, Raichand S, Saidel MA, Hariprasad SM. Microincisional suttureless vitrectomy for dislocated IOL. 2009 Retina Today. Nov/Dec: 32-35.
  • Sheth V, Lin TK, Kiernan DF, Jager RD. Cilary neurotrophic factor in the treatment of advance nonexudative age-related macular degeneration. Retrieved September 29, 2009, from AMD Update. Web site: http://www.lwwvisioncare.com/emails/amdupdate/index.asp?issue=33.
⇧